Literature DB >> 33583408

Muscle activity and acute stress in fibromyalgia.

Teemu Zetterman1,2, Ritva Markkula3, Juhani V Partanen4, Teemu Miettinen3, Ann-Mari Estlander3, Eija Kalso3,5.   

Abstract

BACKGROUND: Fibromyalgia (FM) patients are likely to differ from healthy controls in muscle activity and in reactivity to experimental stress.
METHODS: We compared psychophysiological reactivity to cognitive stress between 51 female FM patients aged 18 to 65 years and 31 age- and sex-matched healthy controls. They underwent a 20-minute protocol consisting of three phases of relaxation and two phases of cognitive stress. We recorded surface electromyography normalized to maximum voluntary muscle contraction (%EMG), the percentage of time with no muscle activity (EMG rest time), and subjective pain and stress intensities. We compared group reactivity using linear modelling and adjusted for psychological and life-style factors.
RESULTS: The FM patients had a significantly higher mean %EMG (2.2 % vs. 1.0 %, p < 0.001), pain intensity (3.6 vs. 0.2, p < 0.001), and perceived stress (3.5 vs. 1.4, p < 0.001) and lower mean EMG rest time (26.7 % vs. 47.2 %, p < 0.001). In the FM patients, compared with controls, the pain intensity increased more during the second stress phase (0.71, p = 0.028), and the %EMG decreased more during the final relaxation phase (-0.29, p = 0.036). Within the FM patients, higher BMI predicted higher %EMG but lower stress. Leisure time physical activity predicted lower %EMG and stress and higher EMG rest time. Higher perceived stress predicted lower EMG rest time, and higher trait anxiety predicted higher pain and stress overall.
CONCLUSIONS: Our results suggest that repeated cognitive stress increases pain intensity in FM patients. FM patients also had higher resting muscle activity, but their muscle activity did not increase with pain. Management of stress and anxiety might help control FM flare-ups. TRIAL REGISTRATION: Retrospectively registered on ClinicalTrials.gov ( NCT03300635 ).

Entities:  

Mesh:

Year:  2021        PMID: 33583408      PMCID: PMC7883576          DOI: 10.1186/s12891-021-04013-1

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  22 in total

Review 1.  Do we need a third mechanistic descriptor for chronic pain states?

Authors:  Eva Kosek; Milton Cohen; Ralf Baron; Gerald F Gebhart; Juan-Antonio Mico; Andrew S C Rice; Winfried Rief; A Kathleen Sluka
Journal:  Pain       Date:  2016-07       Impact factor: 6.961

2.  Psychophysiological responses in patients with fibromyalgia syndrome.

Authors:  Kati Thieme; Ulrike Rose; Thomas Pinkpank; Claudia Spies; Dennis C Turk; Herta Flor
Journal:  J Psychosom Res       Date:  2006-11       Impact factor: 3.006

3.  EMG activity and pain development in fibromyalgia patients exposed to mental stress of long duration.

Authors:  D Bansevicius; R H Westgaard; T Stiles
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

4.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

5.  Normalizing shoulder EMG: An optimal set of maximum isometric voluntary contraction tests considering reproducibility.

Authors:  Cédric Schwartz; François Tubez; François-Charles Wang; Jean-Louis Croisier; Olivier Brüls; Vincent Denoël; Bénédicte Forthomme
Journal:  J Electromyogr Kinesiol       Date:  2017-08-18       Impact factor: 2.368

Review 6.  Evaluating psychosocial contributions to chronic pain outcomes.

Authors:  S M Meints; R R Edwards
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-01-31       Impact factor: 5.067

Review 7.  Neurobiology of fibromyalgia and chronic widespread pain.

Authors:  Kathleen A Sluka; Daniel J Clauw
Journal:  Neuroscience       Date:  2016-06-09       Impact factor: 3.590

8.  Stress-induced allodynia--evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress.

Authors:  Benjamin Crettaz; Martin Marziniak; Peter Willeke; Peter Young; Dirk Hellhammer; Astrid Stumpf; Markus Burgmer
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

9.  Stress levels predict substantial improvement in pain intensity after 10 to 12 years in women with fibromyalgia and chronic widespread pain: a cohort study.

Authors:  Anna Bergenheim; Sofia Juhlin; Lena Nordeman; Monica Joelsson; Kaisa Mannerkorpi
Journal:  BMC Rheumatol       Date:  2019-06-24

10.  An internet survey of 2,596 people with fibromyalgia.

Authors:  Robert M Bennett; Jessie Jones; Dennis C Turk; I Jon Russell; Lynne Matallana
Journal:  BMC Musculoskelet Disord       Date:  2007-03-09       Impact factor: 2.362

View more
  4 in total

1.  Evaluation of Physiotherapy Impact on Neuromuscular Tension in Analog Astronauts at the LunAres Habitat.

Authors:  Barbara Gronwald; Karina Kijak; Piotr Baszuk; Danuta Lietz-Kijak; Kamil Kosko; Mikołaj Matuszczak; Piotr Skomro; Hanna Bielawska-Victorini; Leszek Orzechowski; Agata Mintus; Helena Gronwald
Journal:  Int J Environ Res Public Health       Date:  2022-06-04       Impact factor: 4.614

2.  Glucose tolerance in fibromyalgia.

Authors:  Teemu Zetterman; Ritva Markkula; Eija Kalso
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

3.  Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study.

Authors:  Lionel Noah; Veronique Morel; Claire Bertin; Etienne Pouteau; Nicolas Macian; Christian Dualé; Bruno Pereira; Gisèle Pickering
Journal:  Nutrients       Date:  2022-04-29       Impact factor: 5.717

4.  Elevated highly sensitive C-reactive protein in fibromyalgia associates with symptom severity.

Authors:  Teemu Zetterman; Ritva Markkula; Eija Kalso
Journal:  Rheumatol Adv Pract       Date:  2022-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.